“…In this context, hydrolysates and peptides displaying a range of in vitro bioactivities including other antidiabetic (e.g., α‐glucosidase inhibition), antioxidant, and antihypertensive effects have been described in the literature (Connolly, Piggott, & FitzGerald, ; Harnedy & FitzGerald, ; Lacroix, Meng, Cheung, & Li‐Chan, ; Mojica, Luna‐Vital, & González de Mejía, ; Neves, Harnedy, & FitzGerald, ; Nongonierma & FitzGerald, ; T.‐Y. Wang, Hsieh, et al, ; C. Zhang, Zhang, Wang, Chen, & Luo, ). - Potent DPP‐IV inhibitory peptides have been identified in several food protein‐derived hydrolysates. However, the amounts of these peptides in hydrolysate samples as well as their yield following release from proteins during enzymatic hydrolysis are essentially unknown.
…”